Expression of P16ink4a In Cervical Intraepithelial Neoplasia And Invasive Squamous Cell Carcinoma Of Uterine Cervix

doi:10.5281/zenodo.7791645

International Journal of Medical and Pharmaceutical Research

2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7791645

Original Article

Expression of P16ink4a In Cervical Intraepithelial Neoplasia And Invasive Squamous Cell Carcinoma Of Uterine Cervix

Dr. PavuluriNeelima

Dr. Sucharita Kakaturu

Dr. Swetha Annaram

Dr.Kanigiri Lavanya

DOI : 10.5281/zenodo.7791645

Published

April 1, 2023

Abstract

Carcinoma’s of cervix remains a major killer in women in the developing world including India. According to recent data provided by the atlas of cancer in India project by the ICMR, cervical cancer is the second most common cancer in women after breast cancer .In our country , cervical cancer shows an incidence of 25 per 1,00,000 women. The association of cervical cancer with high risk HPV infection has long been established. The protein p16 serves as a surrogate marker for the oncogenic activities of HPV in replication – competent cells of cervical epithelia and its over expression is well established in CIN and invasive squamous cell carcinoma by many studies. SUMMARY: P16 can be used as a marker for determining HPV infection in Cervical intraepithelial neoplasms (CIN) and Squamous cell carcinoma (SCC) of cervix where there is non-availabitlity of HPV-PCR method in a tertiary care Hospital

Recommended Articles

Volume-4, Issue-2

Downloads

Download PDF pdf

Download XML

Citations

1847 Views

450 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.